Tokushima, Japan

Kohei Akazawa



 

Average Co-Inventor Count = 22.0

ph-index = 2

Forward Citations = 9(Granted Patents)


Company Filing History:


Years Active: 2011-2018

Loading Chart...
Loading Chart...
Loading Chart...
5 patents (USPTO):Explore Patents

Title: Kohei Akazawa: Innovator in Pharmaceutical Chemistry

Introduction

Kohei Akazawa, an accomplished inventor based in Tokushima, Japan, has made significant contributions to the field of pharmaceutical chemistry. With a portfolio of five patents, Akazawa is known for his inventive work on compounds that play a crucial role in therapeutic applications.

Latest Patents

Among Kohei Akazawa’s recent patents are innovative N,N-substituted 3-aminopyrrolidine compounds that are useful as monoamines reuptake inhibitors. The patents present pyrrolidine compounds of General Formula (1) or their salts, with specified derivatives including phenyl or pyridyl groups. These compounds may have substituents selected from halogen atoms and lower alkyl groups, allowing for various modifications. The inventive compounds are positioned to enhance pharmaceutical preparations, providing a broader therapeutic spectrum and demonstrating sufficient therapeutic effects following short-term administration.

Career Highlights

Kohei Akazawa's work is primarily associated with Otsuka Pharmaceutical Company, Limited, where he has contributed his expertise in developing novel pharmaceutical compounds. His focus on creating effective therapeutic agents showcases his commitment to addressing healthcare needs through innovation.

Collaborations

In his professional journey, Akazawa has collaborated with notable colleagues, including Muneaki Kurimura and Shinichi Taira. Their combined efforts and shared expertise have likely fostered significant advancements in pharmaceutical research and development.

Conclusion

Kohei Akazawa's inventive contributions to pharmaceutical chemistry illustrate his role as a key player in advancing therapeutic solutions. With a strong patent portfolio and meaningful collaborations, he continues to push the boundaries of pharmaceutical innovation at Otsuka Pharmaceutical Company, Limited.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…